U.S Physical Therapy PE Ratio 2010-2024 | USPH

Current and historical p/e ratio for U.S Physical Therapy (USPH) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. U.S Physical Therapy PE ratio as of July 22, 2024 is 38.74.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

U.S Physical Therapy PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-07-22 96.08 78.11
2024-03-31 112.39 $1.23 91.37
2023-12-31 92.36 $1.35 68.42
2023-09-30 90.52 $1.72 52.63
2023-06-30 119.28 $1.93 61.80
2023-03-31 95.84 $2.16 44.37
2022-12-31 78.96 $2.25 35.09
2022-09-30 73.72 $2.99 24.66
2022-06-30 105.38 $2.93 35.97
2022-03-31 95.60 $2.88 33.19
2021-12-31 91.45 $2.42 37.79
2021-09-30 105.46 $2.37 44.50
2021-06-30 110.09 $2.32 47.45
2021-03-31 98.61 $2.49 39.60
2020-12-31 113.58 $2.83 40.13
2020-09-30 82.06 $2.81 29.20
2020-06-30 76.53 $3.05 25.09
2019-12-31 107.59 $2.45 43.91
2019-09-30 122.51 $2.33 52.58
2019-06-30 114.77 $1.87 61.37
2019-03-31 98.12 $1.15 85.32
2018-12-31 95.37 $1.24 76.91
2020-03-31 65.17 $1.08 60.35
2018-09-30 110.29 $1.45 76.06
2018-06-30 89.09 $1.73 51.50
2018-03-31 75.26 $1.64 45.89
2017-12-31 66.65 $1.75 38.09
2017-09-30 56.56 $1.66 34.07
2017-06-30 55.41 $1.71 32.40
2017-03-31 59.53 $1.89 31.50
2016-12-31 64.00 $1.94 32.99
2016-09-30 57.01 $1.94 29.38
2016-06-30 54.59 $1.95 27.99
2016-03-31 44.95 $1.89 23.78
2015-12-31 48.36 $1.80 26.87
2015-09-30 40.32 $1.73 23.30
2015-06-30 49.04 $1.69 29.02
2015-03-31 42.41 $1.71 24.80
2014-12-31 37.35 $1.72 21.71
2014-09-30 31.40 $1.63 19.27
2014-06-30 30.24 $1.22 24.79
2014-03-31 30.46 $1.10 27.69
2013-12-31 30.95 $1.06 29.20
2013-09-30 27.19 $1.08 25.18
2013-06-30 24.10 $1.44 16.74
2013-03-31 23.32 $1.44 16.20
2012-12-31 23.82 $1.82 13.09
2012-09-30 23.46 $1.82 12.89
2012-06-30 21.52 $1.85 11.63
2011-12-31 16.52 $1.75 9.44
2011-09-30 15.48 $1.41 10.98
2011-06-30 20.59 $1.45 14.20
2011-03-31 18.54 $1.37 13.53
2010-12-31 16.32 $1.44 11.33
2012-03-31 19.43 $1.36 14.29
2010-09-30 13.77 $1.17 11.77
2010-06-30 13.90 $1.10 12.64
2010-03-31 14.33 $1.03 13.91
2009-12-31 13.94 $0.99 14.08
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.448B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $18.408B 11.14
Quest Diagnostics (DGX) United States $16.369B 16.92
DaVita (DVA) United States $12.274B 15.25
Encompass Health (EHC) United States $8.690B 22.25
Chemed (CHE) United States $8.208B 25.44
Elanco Animal Health (ELAN) United States $6.326B 16.41
Option Care Health (OPCH) United States $5.413B 20.49
RadNet (RDNT) United States $4.626B 96.34
Amedisys (AMED) United States $3.184B 22.56
Astrana Health (ASTH) United States $2.784B 37.66
Addus HomeCare (ADUS) United States $2.196B 28.43
LifeStance Health (LFST) United States $2.133B 0.00
Pennant (PNTG) United States $0.836B 44.19
Aveanna Healthcare Holdings (AVAH) United States $0.770B 0.00
Atai Life Sciences (ATAI) Germany $0.249B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.018B 0.00
Ontrak (OTRK) United States $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Novo Integrated Sciences (NVOS) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00